Last updated July 2026.
Healthcare is one of the highest-stakes verticals in generative search. According to a WebFX analysis of more than 130,000 U.S. healthcare search queries, Google AI Overviews appear in approximately 51% of healthcare searches, rising to 66.9% for informational-intent queries specifically. Both figures are roughly double the cross-industry average. (Note: WebFX is a digital marketing agency; this is a single vendor’s study, not independently peer-reviewed.)
A patient or prescriber asking a drug-comparison question is now more likely to see an AI-generated answer than a traditional results page. And in almost every case, that AI answer cites PubMed, Mayo Clinic, WebMD, or a formulary database. Not the brand page.
This playbook shows you how to close that gap within regulatory constraints.
Step 1: Map where AI engines cite today for your category queries
You cannot fix a gap you have not measured. Before writing a single word of content, run your highest-priority drug-comparison queries through an AI citation monitoring tool.
Temso is the easiest starting point. From $89/mo, it tracks citation share across eight AI engines (ChatGPT, Perplexity, Gemini, Google AI Overviews, Google AI Mode, Grok, Microsoft Copilot, and Meta AI) and shows you which source URLs each engine pulls from. For a pharma team, the key output is the list of trusted domains for your query cluster. That list tells you exactly where to earn placements.
Profound adds deeper citation-source maps and visual overlays showing citation frequency by domain. Growth plans start at $399/mo. It is more granular than most teams need at the start, but worth evaluating if your medical affairs or regulatory team needs documented evidence of AI citation behavior before approving a content strategy.
SE Visible and Otterly.AI are lower-cost options. SE Visible covers five engines with daily tracking as part of the SE Ranking suite; Otterly.AI has a $29/mo Lite plan with a GEO audit engine that checks 20+ on-page citation-readiness factors.
Run at least 20 queries across three intent types:
- Mechanism queries: “how does [drug] work” or “[drug] mechanism of action”
- Comparison queries: “[drug A] vs [drug B]” or “best treatment for [condition]”
- Formulary queries: “[drug] formulary coverage” or “[drug] prior authorization requirements”
Document every third-party domain that appears. That is your target list.
Step 2: Publish peer-reviewed study summaries in a citation-ready format
The single highest-leverage content move in regulated healthcare GEO is getting clinical evidence into PubMed-indexed journals. This is also the most compliant path: peer-reviewed publication of well-designed studies is not a promotional activity under FDA guidance or MHRA standards.
When a study you funded appears in a peer-reviewed journal, you do not control the text and you do not need to. The journal citation gets indexed in PubMed, and AI engines pull it directly.
What you can control is the content that lives on your own domain alongside that evidence. That content must follow these rules to be citation-ready:
- Put the direct answer first. The first paragraph of any page must stand alone as a complete answer to the query it targets. AI engines extract from the top of the page. A 2026 analysis of ChatGPT citation behavior found 44.2% of citations were drawn from the first 30% of a page’s content. Bury your clinical data below a branded hero section and the engine will likely never reach it.
- Include balanced safety data. Pages that present only efficacy without safety information are read as promotional by AI systems. Include the FDA-approved label language on adverse events and contraindications alongside the efficacy summary.
- Name the study and author. “A 2024 phase III randomized trial published in NEJM by [lead author] et al. found…” is the format AI engines prefer. Unnamed “clinical data” or “studies show” phrasing provides no citation anchor.
- Link to the PubMed record. An outbound link to the PubMed entry for the referenced study signals source authenticity to AI retrieval systems.
Step 3: Build structured formulary comparison content that prescribers actually search for
Formulary and coverage queries are among the highest-volume informational searches in healthcare. Prescribers ask them constantly. AI engines have to answer them from somewhere.
Most pharma brands do not publish structured formulary comparison content, because historically it existed only in print formulary guides or behind PBM portals. That gap is your opportunity.
A compliant formulary comparison page looks like this:
| Attribute | Drug A | Drug B | Drug C |
|---|---|---|---|
| Tier (typical commercial) | Tier 2 | Tier 3 | Tier 1 |
| Prior authorization required | No | Yes | No |
| Step therapy required | No | Yes, after Drug C | No |
| Available as generic | Yes | No | Yes |
| Mechanism of action | [class] | [class] | [class] |
| Key Phase III trial | [trial name, PMID] | [trial name, PMID] | [trial name, PMID] |
| Common adverse events | See full prescribing information | See full prescribing information | See full prescribing information |
A table in this format does three things at once. It gives prescribers the practical comparison they are searching for. It gives AI engines a clean structured data block to extract. And it stays within regulatory bounds because it presents factual formulary and label information rather than superiority claims.
Compliant vs. non-compliant content: the key distinctions
| Element | Compliant | Not compliant |
|---|---|---|
| Efficacy claims | ”Phase III trial [name] showed [X outcome] at [time] (PMID: [number])" | "Drug A is the most effective treatment for [condition]“ |
| Safety presentation | Balanced AE profile from approved label | Omitting AEs or minimizing with “generally well tolerated” without label language |
| Competitor comparison | Factual head-to-head trial data with both arms reported | Selective reporting showing only favorable outcomes |
| Formulary data | Tier, PA requirement, step therapy requirement from publicly available formulary | Implied formulary coverage not supported by actual payer data |
| Target audience | HCP-directed page with appropriate fair balance footer | Mixed HCP/patient page without clear audience designation |
| Superior claims | Avoided; numerical outcomes reported with study citation | ”Drug A outperforms Drug B” without a specific cited trial |
Keep every comparison factual, cited to a specific trial or label section, and balanced. If your regulatory and medical-legal review team would approve it for a detail aid, it is likely appropriate for an HCP-facing web page.
Step 4: Create HCP-directed educational content that fills the third-party citation gap
The content format AI engines cite most often for clinical questions is educational, not promotional. Dosing guides, mechanism-of-action explainers, clinical algorithm support documents, and disease-state education all qualify.
Publish this content on your medical information site or a dedicated HCP portal, clearly gated or labeled as professional content. The label “For healthcare professionals only” signals to AI retrieval systems (and to regulators) that the content is professional education, not direct-to-consumer promotion.
The formats that work best for AI citation in clinical contexts:
Dosing and administration guides. A page structured as “Starting dose: [X mg]. Titration schedule: [Y]. Renal dose adjustment: [Z]. Hepatic dose adjustment: [W].” is highly structured, useful to prescribers, and easy for AI engines to extract verbatim. Include the FDA-approved label section reference for each data point.
Mechanism-of-action explainers. These are pure education, typically permissible without fair balance under FDA guidance. Write them at a level appropriate for a specialist prescriber. Include the biochemical pathway, the therapeutic target, and a link to the primary literature supporting the mechanism.
Clinical algorithm support. Many medical societies publish treatment algorithms for their specialty conditions. If your product fits into a treatment step within a published guideline, publish a page that maps your label indications to that algorithm step. Cite the guideline by name and version. Do not imply guideline endorsement unless you have it in writing.
Step 5: Earn placements on the third-party domains AI engines trust most
Publishing compliant content on your own domain is necessary but not sufficient. The citation data from monitoring tools consistently shows that AI engines in healthcare preferentially cite independent third-party domains. Build a systematic plan to earn placements on them.
Priority third-party targets for pharma GEO:
| Domain type | Examples | How to earn placement |
|---|---|---|
| Peer-reviewed journals | NEJM, JAMA, The Lancet, BMJ | Fund and publish well-designed trials; submit as corresponding author with institutional affiliation |
| Clinical trial registries | ClinicalTrials.gov, EU Clinical Trials Register | Register every trial, update results section promptly after completion |
| Drug information databases | Micromedex, Clinical Pharmacology, Lexicomp | Ensure product monograph is submitted and current; update with new label revisions |
| Clinical decision support | UpToDate, Epocrates, DynaMed | Submit data for formulary inclusion; provide updated drug monograph submissions via established vendor channels |
| Health education sites | Mayo Clinic Health Library, MedlinePlus, NHS Conditions | Submit correction requests when information is outdated; participate in medical education partnerships where permitted |
| Medical society CME | ADA, ACC, ASCO, AAN continuing education portals | Fund unrestricted CME grants; provide faculty support for accredited education (per ACCME standards) |
| Pharmacy benefit resources | Pharmacy Times, Pharmacist’s Letter, Drug Topics | Pitch drug-information articles authored by clinical pharmacists with disclosure of sponsor support |
AI engines have effectively pre-selected a trusted citation network for healthcare queries. Your job is to get your data, your trials, and your clinical expertise onto that network. Do not try to get AI engines to cite your brand page directly. Get them to cite the sources that already cite your data.
Step 6: Add HowTo and FAQPage schema to every compliant page
Once your content is published and compliant, add structured data to improve AI comprehension. Use HowTo schema for dosing guides and administration procedures. Use FAQPage schema for patient education pages and formulary access guides.
One important caveat: a 2026 Ahrefs study tracking 1,885 pages that added JSON-LD schema found no statistically significant uplift in AI citations. Schema improves page comprehension but does not substitute for content quality or source authority. Treat it as a baseline requirement, not a citation lever.
Prioritize these schema types: MedicalCondition, Drug, and MedicalEntity from Schema.org; author markup with Person schema including professional credentials (MD, PharmD); dateModified for content recency signals; and citation within ScholarlyArticle when referencing peer-reviewed studies.
Step 7: Track, measure, and iterate weekly
GEO in a regulated industry moves slowly. Peer-reviewed publication takes months. Formulary database updates follow their own submission cycles. HCP portal content requires medical-legal review. Weekly tracking tells you which content and placements are moving the needle so you prioritize the right next investment.
Use Temso for the core monitoring loop: eight engines, URL-level citation attribution, and citation share trends from $89/mo. For deeper citation-source maps to present to leadership or regulatory affairs, Profound adds per-URL attribution at enterprise pricing. SE Visible suits teams already running SE Ranking.
Measure three things each week:
- Citation rate for your target query cluster: what percentage of AI answers mention your brand or product?
- Citation source: which domain is the AI engine pulling from when it cites you?
- Competitor citation rate: who appears in the answers you are not, and from which domains?
The competitor source list tells you exactly where to invest next.
Start here
For the broader citation-building foundation, the citation share playbook covers the three interventions that consistently move citation share. The full GEO tool ranking compares every major platform on closed-loop depth and engine coverage. The GEO glossary defines citation share, share of voice, and other terms used above.
If you are starting a pharma GEO program from zero, Temso is the straightforward entry point: eight engines, citation-source attribution, and a $89/mo flat rate with no specialist required. Start there, build your baseline, then invest in content and third-party placements where the data shows the gaps.